PTPN11 and juvenile myelomonocytic leukemia: It is notable that the HSCs from one of the JMML patients (ID23) contain mutations in both Shp2 and Ras, but their hyper-proliferation was comparably attenuated by SFX-01 to those with mutations solely in the phosphatase.